
|Articles|November 6, 2015
Pediatric Drug Development & Therapeutics in October TIRS
Author(s)DIA
Advertisement
The Special Section on Pediatric Therapeutics in the November, 2015 issue of
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5




